Advanced search

You are trying to reach document intended for healthcare professionals only

Letters to HCPs

{pdf_link}

Esmya (UPA) 5mg - UK DHCP 29.01.2021

{healthcare_pro_orange} For Healthcare Professionals
This is a DHCP letter in agreement with the EMA and MHRA concerning new restrictions on the use of Esmya 5mg Tablets (ulipristal acetate) following conclusion of an Article 31 safety review.

Are you a healthcare professional?